Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028

CureVac NV

24/11/2025 12:13

Nov 24 (Reuters) - CUREVAC NV 5CV.DE:

CUREVAC Q3 REVENUE EUR 54.1 MILLION VERSUS. IBES ESTIMATE EUR 3.34 MILLION

CUREVAC Q3 EBIT EUR 310.2 MILLION

CUREVAC NV - COMPANY REAFFIRMS ITS EXPECTED CASH RUNWAY INTO 2028

CUREVAC NV - GERMAN FEDERAL CARTEL OFFICE CLEARS BIONTECH-CUREVAC DEAL

CUREVAC NV - NET FINANCIAL RESULT FOR THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025, WAS LOSS OF EUR 2.6 MILLION AND GAIN OF EUR 2.2 MILLION, RESPECTIVELY

Source text: ID:nEQ38YbzSa

Further company coverage: 5CV.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))